Atricure to present at the 31st annual canaccord genuity growth conference

West chester, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, today announced that it will present at the 31st annual canaccord genuity growth conference at the intercontinental hotel in boston on wednesday, august 10, 2011. management is scheduled to present at 11:30 a.m. eastern time. a live audio webcast and replay of the presentation will be available for 30 days following the presentation at www.atricure.com. about atricure, inc.atricure, inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue and systems for the exclusion of the left atrial appendage. for more information, please visit www.atricure.com.
ATRC Ratings Summary
ATRC Quant Ranking